Company news

Zoetis Inc. news in 2026

Zoetis Inc.'s news releases, calls and decks from 2026, newest first.

View company

Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment

October 20, 2026

Zoetis Appoints Iris Knobloch to its Board of Directors

October 13, 2026

Zoetis Declares Fourth Quarter 2026 Dividend

October 8, 2026

Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results

September 24, 2026

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 2, 2026

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

August 13, 2026

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

August 6, 2026

Zoetis Announces Second Quarter 2026 Results

August 6, 2026

Zoetis Receives Approval for Portela® (relfovetmab injection) in Great Britain

July 30, 2026

Zoetis Launches Portela® (relfovetmab) in Canada and the European Union

July 22, 2026

Zoetis' acquisition of Neogen Genomics requires Phase 2 review

July 17, 2026

Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union

July 15, 2026

Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities

July 14, 2026

Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND

July 7, 2026

Zoetis to Host Webcast and Conference Call on Second Quarter 2026 Financial Results

June 25, 2026

Zoetis Declares Third Quarter 2026 Dividend

May 20, 2026

Zoetis Announces First Quarter 2026 Results

May 7, 2026

Techcyte Announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability

April 30, 2026

Zoetis Equine Renews Title Sponsorship for the 2026 Horses for Mental Health Campaign

April 6, 2026

Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results

April 2, 2026

Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

March 12, 2026

Zoetis expands Human-Animal Bond Certification scholarship to include veterinary technician students

March 10, 2026

Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

March 2, 2026

Neogen Announces Sale of Genomics Business to Zoetis

March 2, 2026

Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

February 24, 2026

Zoetis Reports Fourth Quarter and Full Year 2025 Results

February 12, 2026

Zoetis Declares Second Quarter 2026 Dividend

February 5, 2026

Calls in 2026

Decks in 2026